CN105641215A - Health product composition with weight-reducing effect and preparation method thereof - Google Patents
Health product composition with weight-reducing effect and preparation method thereof Download PDFInfo
- Publication number
- CN105641215A CN105641215A CN201610019687.2A CN201610019687A CN105641215A CN 105641215 A CN105641215 A CN 105641215A CN 201610019687 A CN201610019687 A CN 201610019687A CN 105641215 A CN105641215 A CN 105641215A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- halth
- weight
- care composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 230000000694 effects Effects 0.000 title abstract description 25
- 230000036541 health Effects 0.000 title abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 240000004153 Hibiscus sabdariffa Species 0.000 claims abstract description 20
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims abstract description 20
- 235000004347 Perilla Nutrition 0.000 claims abstract description 20
- 244000269722 Thea sinensis Species 0.000 claims abstract description 20
- 235000009569 green tea Nutrition 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000010438 heat treatment Methods 0.000 claims description 26
- 230000009471 action Effects 0.000 claims description 23
- 230000003579 anti-obesity Effects 0.000 claims description 22
- 238000011049 filling Methods 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 20
- 241001164374 Calyx Species 0.000 claims description 19
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 238000010792 warming Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 240000000560 Citrus x paradisi Species 0.000 claims description 4
- 239000004376 Sucralose Substances 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 4
- 235000019408 sucralose Nutrition 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 238000003672 processing method Methods 0.000 claims description 2
- 230000004060 metabolic process Effects 0.000 abstract description 7
- 230000001603 reducing effect Effects 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 208000008589 Obesity Diseases 0.000 abstract description 3
- 235000019577 caloric intake Nutrition 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 239000011707 mineral Substances 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 235000020824 obesity Nutrition 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 235000021332 kidney beans Nutrition 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 210000000577 adipose tissue Anatomy 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 210000004003 subcutaneous fat Anatomy 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- LCCDINSFSOALJK-UHFFFAOYSA-N 1,3,4-trimethylpurine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2(C)N=CN=C21 LCCDINSFSOALJK-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000852 deltoid muscle Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N trimethylxanthine Natural products CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a health product composition with a weight-reducing effect and a preparation method thereof. The composition is prepared from the following components in parts by weight: 200-500 parts of green tea, 500-1000 parts of white kidney beans, 100-500 parts of purple perilla, 100-500 parts of roselle, 100-300 parts of ground coffee, 6843-8989 parts of pure water, 1 part of a sweetening agent and 10 parts of essence. By adopting the health product composition with a weight-reducing effect and the preparation method thereof, the prepared preparation is a compound liquid preparation, does not have toxic or side effect, has a weight-reducing effect, and can be used for avoiding simple obesity. The raw materials used in the formula accord with related specifications in China, are safe and do not have toxic or side effect. The preparation has a remarkable weight-reducing effect, is healthy to human bodies, and does not have remarkable hurt on human bodies. According to the composition, multiple ingredients are coordinated from the aspects of respectively supplying various nutrient minerals, accelerating fat metabolism, promoting caloric intake reduction, promoting consumption of heat in bodies and the like so as to achieve a good weight reducing effect.
Description
Technical field
The present invention relates to field of health care products, particularly relate to the healthcare products with antiobesity action, specifically refer to a kind of Halth-care composition and its preparation method with antiobesity action.
Background technology
According to the numeral that relevant department of China announces, the current population of being obese of China reaches 3.25 hundred million people, has 17% to be obese person in China's urban population, and the children of China have 51% to be obese person. Deliver one part of the World Health Organization is reported, whole world population of being obese sharp increase in past 20 years, the whole world has 1,000,000,000 people and belongs to obese person. For Britain, the proportion of fat number almost added one times in 20 years. The ratio of male overweight person rises to the 17% of last year from the 8% of the eighties in last century. The market of slimming health product and medicine is up to hundreds billion of, and the market requirement is more healthy and safe, the product of more remarkable effect.
Summary of the invention
It is an object of the invention to overcome the shortcoming of prior art, it provides a kind of Halth-care composition and its preparation method with antiobesity action.
In order to realize above-mentioned purpose, the Halth-care composition with antiobesity action of the present invention and its preparation method have following formation:
This has the Halth-care composition of antiobesity action, and its principal feature is, described composition comprises according to weight part number:
Green tea 200��500 parts, Semen Phaseoli Vulgaris 500��1000 parts, purple perilla 100��500 parts, Roselle Calyx 100��500 parts, coffee powder 100��300 parts, pure water 6843��8989 parts, sweeting agent 1 part and 10 parts, essence.
Preferably, described sweeting agent is Sucralose.
More preferably, described essence is grapefruit essence.
Further preferably, described composition comprises according to weight part number: green tea 400��500 parts, Semen Phaseoli Vulgaris 900��1000 parts, purple perilla 400��500 parts, Roselle Calyx 400��500 parts, coffee powder 150��250 parts, pure water 7239��7739 parts, sweeting agent part 1 part and 10 parts, essence.
Again further preferably, described green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx are what Processing methods was crossed.
The preparation method with the Halth-care composition of antiobesity action, its principal feature is, described preparation method comprises the steps:
(1) described green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx being weighed in placement decoction pot by prescription, first time adds water 8��10 times, and heating is decocted and boiled 2 hours, filters; Filter residue second time adds water 4��6 times, and heating is decocted and boiled 2 hours, filters; Filter residue third time adds water 2��3 times, and heating is decocted and boiled 1.5 hours, filters;
(2) merging three decoction liquor under clean environment, filter, get rid of insolubles after leaving standstill 24h, filtrate is for concentration;
(3) under clean environment, concentrated filtrate to density is 1.25;
(4) pure water is added to, in Cooling or heating jar, starting agitator and be warming up to 65 DEG C��70 DEG C, add concentrated medicine juice stirring and dissolving;
(5) add pure water to, in Cooling or heating jar, starting agitator and be warming up to 65 DEG C��70 DEG C, described coffee powder is joined jacketed kettle, adds in Cooling or heating jar after mixing, add and fashionable enter Cooling or heating jar by 120 mesh filter screens by colloidal mill;
(6) keep temperature in Cooling or heating jar, add remaining raw material stirring and dissolve.
Preferably, described clean environment is 100,000 grades of clean environments.
More preferably, described step (3) is specially:
Under 100,000 grades of clean environments, by the filtrate after above-mentioned purification, concentrated pressure is 0.05mpa, temperature is 60 DEG C, and the time is 12 hours, concentrate to relative density about 1.25, make concoction amount equal with the weight of the green tea originally dropped into, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx.
Further preferably, described preparation method also comprises after step (6):
(7) under 25mpa, the material after stirring being crossed clarifixator, temperature of charge remains on 70 DEG C;
(8) it is warming up to 80 DEG C and keeps constant temperature, filling;
(9) putting into sterilization cabinet sterilization after filling and sealing, 110 DEG C of sterilization 20min, obtain finished product.
Most preferably, described step (8) is specially:
It is warming up to 80 DEG C and keeps constant temperature, while it is filling to cross clarifixator limit, crosses 120 mesh filter screens before filling, stir filling.
Have employed the Halth-care composition with antiobesity action in this invention and its preparation method, obtained preparation is compound liquid preparation, has no side effect, and has the effect of fat-reducing, it is possible to prevent simple obesity. This formula is raw materials used is the relevant regulations meeting country, safe without toxic side effect, and human body is had obvious antiobesity action by this preparation, and to body health without obvious damage. Multiple composition from many aspects coordinative roles such as supplementary various nutrient substance mineral substance, acceleration metabolism of fat, minimizing energy intake and promotion intimate heat consumption, reaches the effect of fat-reducing preferably respectively.
Embodiment
In order to more clearly describe the technology contents of the present invention, conduct further description below in conjunction with specific embodiment.
The efficacy effect of raw material:
Effect of green tea: it is tea-polyphenol, trimethyl-xanthine, lipopolysaccharides, theanine etc. that green tea has the major ingredient of pharmacological action, has the function of well weight reducing fat reducing. The Tang Dynasty " Bencao Shiyi " records " food of a specified duration makes us thin ", illustrates that in the Tang Dynasty be epoch of U.S. taking fat, just knows that green tea has effect of fat-reducing.
Effect of Semen Phaseoli Vulgaris: 1, eliminate fat: metabolism of fat can be accelerated, reduce triglyceride level, reduce cholesterol, suppress the activity of cholesterol in human body synthetic enzyme, thus reduce the absorption of cholesterol in human body, contained Mierocrystalline cellulose can assist to excrete fat too much in enteron aisle, sugar, toxin, plays effect for reducing fat. 2, contributing to eliminating carbohydrate: carbohydrate can improve glucose level, thus stimulates the secretion of Regular Insulin, Regular Insulin can shift blood sugar again and be stored up and become fat, and blood sugar reduces and cause appetite and feed again simultaneously.Semen Phaseoli Vulgaris can reduce the absorption of carbohydrate, thus plays the effect of fat-reducing. 3, reduce appetite: Semen Phaseoli Vulgaris can stimulate nervus centralis, make people excited, thus reduce appetite. 4, metabolism: Semen Phaseoli Vulgaris can promote the metabolism of human body each portion technical ability, improves the weave construction of internal organ function, accelerates the metabolism of fat, consumed energy.
Effect of purple perilla: research proves, the perilla oil in purple perilla can control the cohesion of blood in human body in platelet, reduces the neutral lipid in blood, removes cholesterol, prevents thrombosis.
Effect of Roselle Calyx: the nutritions such as the vitamins C that contains in Roselle Calyx, Williams Elder Twig three glucosides, citric acid, is of value to and regulating and balancing blood fat promoting digestion etc. Scientific research personnel also finds the total cholesterol value that Roselle Calyx contributes to reducing in blood of human body and triglyceride value, reaches prevention and cure of cardiovascular disease, antiobesity action.
After trimethyl-xanthine in coffee powder is absorbed by the body, in body, activity makes body secretes go out suprarenin, and this kind of material can promote the decomposition campaign of the adipocyte in blood.
Embodiment 1:
The raw material taking following portions by weight is made: green tea 200 parts, Semen Phaseoli Vulgaris 500 parts, purple perilla 100 parts, Roselle Calyx 100 parts, coffee powder 100 parts, pure water 8989 parts, Sucralose: 1 part, grapefruit essence: 10 parts. By green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx, weighing by prescription and place in decoction pot, first time adds water 8 times, and heating is decocted and boiled 2 hours, filters; Filter residue second time adds water 4 times, and heating is decocted and boiled 2 hours, filters; Filter residue third time adds water 2 times, and heating is decocted and boiled 1.5 hours, filters. Under 100,000 grades of clean environments, merging three decoction liquor, leave standstill after 24 hours, filter, get rid of insolubles, filtrate is for concentration. Under 100,000 grades of clean environments, by the filtrate after above-mentioned purification, concentrate to relative density about 1.25 (concentrated pressure is 0.05mpa, temperature is 60 DEG C, and the time is 12 hours), concoction amount and original drop into green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx weight equal. Appropriate amount of purified water is injected Cooling or heating jar start agitator and be warming up to 70 DEG C, add the inspissated juice stirring and dissolving weighed up. Pure water is joined jacketed kettle, starts agitator and be warming up to 70 DEG C, then coffee powder raw material will be weighed up mix and join jacketed kettle by mixing of materials pump, be filtered through colloidal mill by 120 mesh filter screens after solvent and enter hot cylinder. In Cooling or heating jar, the temperature of material controls at about 70 DEG C, adds remaining raw material stirring and dissolves. After the material of jacketed kettle enters hot cylinder, material temperature remains on 70 DEG C, crosses clarifixator (pressure 25). Material stirs after having crossed clarifixator and is warmed up to 80 DEG C, it is possible to while it is filling to cross clarifixator limit, filling 120 mesh filter screens before filling, time filling, material temperature remains on about 80 DEG C, slowly stirs. Wash bottle, filling, sealing. Sterilization cabinet sterilization, sterilization parameter: 110 degree 20 minutes. Obtain finished product.
Embodiment 2:
The raw material taking following portions by weight is made: green tea 500 parts, Semen Phaseoli Vulgaris 1000 parts, purple perilla 500 parts, Roselle Calyx 500 parts, coffee powder 200 parts, pure water 7289 parts, Sucralose: 1 part, grapefruit essence: 10 parts. By green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx, weighing by prescription and place in decoction pot, first time adds water 8 times, and heating is decocted and boiled 2 hours, filters; Filter residue second time adds water 4 times, and heating is decocted and boiled 2 hours, filters; Filter residue third time adds water 2 times, and heating is decocted and boiled 1.5 hours, filters. Under 100,000 grades of clean environments, merging three decoction liquor, leave standstill after 24 hours, filter, get rid of insolubles, filtrate is for concentration.Under 100,000 grades of clean environments, by the filtrate after above-mentioned purification, concentrate to relative density about 1.25 (concentrated pressure is 0.05mpa, temperature is 60 DEG C, and the time is 12 hours), concoction amount and original drop into green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx weight equal. Appropriate amount of purified water is injected Cooling or heating jar start agitator and be warming up to 70 DEG C, add the inspissated juice stirring and dissolving weighed up. Pure water is joined jacketed kettle, starts agitator and be warming up to 70 DEG C, then coffee powder raw material will be weighed up mix and join jacketed kettle by mixing of materials pump, be filtered through colloidal mill by 120 mesh filter screens after solvent and enter hot cylinder. In Cooling or heating jar, the temperature of material controls at about 70 DEG C, adds remaining raw material stirring and dissolves. After the material of jacketed kettle enters hot cylinder, material temperature remains on 70 DEG C, crosses clarifixator (pressure 25). Material stirs after having crossed clarifixator and is warmed up to 80 DEG C, it is possible to while it is filling to cross clarifixator limit, filling 120 mesh filter screens before filling, time filling, material temperature remains on about 80 DEG C, slowly stirs. Wash bottle, filling, sealing. Sterilization cabinet sterilization, sterilization parameter: 110 degree 20 minutes. Obtain finished product.
Bodily fuctions's examination conclusion:
1, effect of weight reducing test situation
1,1 generalized case: the edible sample of test-meal group experimenter is after 90 days, and oneself's sensation mental status, sleeps all right, and stool and urine is normal. Do not find other untoward reaction; Before 108 subject, testing latter one day total food-intake, run duration and sports events are substantially constant. (see table 1)
Diet before and after table 1 is edible, motion conditions compares
Note: above every test-meal group, compares p before and after control group test-meal > 0.05
1.2 functional observation
Body weight before and after 1.3 test-meals, body fat total amount and fat percentage measure
Experimenter tests rear weight average decline 2.6kg, and total amount of body fat on average declines 2.3kg, and Rate of body lipid on average declines 2.0%. Weight average rising 0.3kg after control group test, total amount of body fat on average rises 0.2kg, and Rate of body lipid on average rises 0.1%. After the test of test-meal group, comparing difference has significance (p < 0.01) before above three indexs and test and after control group test, the results are shown in Table 2.
Front and back body weight taken by table 2, body fat, Rate of body lipid changing conditions
Before and after 1.4 test-meals, subcutaneous fat thickness and girth diameter are measured
Interviewee tests rear average subcutaneous fat thickness: outside deltoid muscle lower edge, positive mid point reduces 1.0mm, and under omoplate, angle place reduces 2.6mm, and the other 3cm place of navel reduces 1.3mm, anterior superior spine place reduces 3.2mm, waistline reduces 4.2cm, and hip circumference reduces 2.3cm, and abdominal circumference reduces 3.5cm. Average subcutaneous fat thickness after control group test: outside deltoid muscle lower edge, positive mid point increases 0.1mm, angle place under omoplate, the other 3cm place of navel, anterior superior spine place increases 0.0mm, and waistline increases 0.2cm, and hip circumference increases 0.2cm, and abdominal circumference increases 0.1cm. Every index more than after test is set up in test-meal and test-meal is front and after control group test, comparing difference has significance (p < 0.01) such as following table 3:
Table 3 takes front and back subcutaneous fat thickness and girth diameter changing conditions
Experimenter eats this oral liquid formulations after 90 days continuously, and body weight, body fat total amount, Rate of body lipid significantly declines. Weight loss 2.6kg, body fat decline 2.3kg, Rate of body lipid decline 2.0%, subcutaneous fat thickness and waistline, hip circumference, abdominal circumference significantly reduces, and test-meal group tests front and back and between test-meal group and control group group, comparing difference all has significance (p < 0.05, p < 0.01).Exercise tolerance does not decline, experimenter's routine blood test, the every index of other blood biochemicals, blood uric acid, heart rate, and blood pressure is all in normal range, and urine ketoboidies, routine urinalysis, just conventional negative, electrocardiogram(ECG, Chest X-rays, the item inspections such as B ultrasonic are all no abnormal.
Have employed the Halth-care composition with antiobesity action in this invention and its preparation method, obtained preparation is compound liquid preparation, has no side effect, and has the effect of fat-reducing, it is possible to prevent simple obesity. This formula is raw materials used is the relevant regulations meeting country, safe without toxic side effect, and human body is had obvious antiobesity action by this preparation, and to body health without obvious damage. Multiple composition from many aspects coordinative roles such as supplementary various nutrient substance mineral substance, acceleration metabolism of fat, minimizing energy intake and promotion intimate heat consumption, reaches the effect of fat-reducing preferably respectively.
In this description, the present invention is described with reference to its specific embodiment. But, it is clear that still can make various amendment and conversion and not deviate from the spirit and scope of the present invention. Therefore, specification sheets is regarded in an illustrative, rather than a restrictive.
Claims (10)
1. one kind has the Halth-care composition of antiobesity action, it is characterised in that, described composition comprises according to weight part number:
Green tea 200��500 parts, Semen Phaseoli Vulgaris 500��1000 parts, purple perilla 100��500 parts, Roselle Calyx 100��500 parts, coffee powder 100��300 parts, pure water 6843��8989 parts, sweeting agent 1 part and 10 parts, essence.
2. the Halth-care composition with antiobesity action according to claim 1, it is characterised in that, described sweeting agent is Sucralose.
3. the Halth-care composition with antiobesity action according to claim 1, it is characterised in that, described essence is grapefruit essence.
4. the Halth-care composition with antiobesity action according to claim 1, it is characterized in that, described composition comprises according to weight part number: green tea 400��500 parts, Semen Phaseoli Vulgaris 900��1000 parts, purple perilla 400��500 parts, Roselle Calyx 400��500 parts, coffee powder 150��250 parts, pure water 7239��7739 parts, sweeting agent part 1 part and 10 parts, essence.
5. the Halth-care composition with antiobesity action according to claim 1, it is characterised in that, described green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx are what Processing methods was crossed.
6. the preparation method of the Halth-care composition with antiobesity action according to claim 1, it is characterised in that, described preparation method comprises the steps:
(1) described green tea, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx being weighed in placement decoction pot by prescription, first time adds water 8��10 times, and heating is decocted and boiled 2 hours, filters; Filter residue second time adds water 4��6 times, and heating is decocted and boiled 2 hours, filters; Filter residue third time adds water 2��3 times, and heating is decocted and boiled 1.5 hours, filters;
(2) merging three decoction liquor under clean environment, filter, get rid of insolubles after leaving standstill 24h, filtrate is for concentration;
(3) under clean environment, concentrated filtrate to density is 1.25;
(4) pure water is added to, in Cooling or heating jar, starting agitator and be warming up to 65 DEG C��70 DEG C, add concentrated medicine juice stirring and dissolving;
(5) add pure water to, in Cooling or heating jar, starting agitator and be warming up to 65 DEG C��70 DEG C, described coffee powder is joined jacketed kettle, adds in Cooling or heating jar after mixing, add and fashionable enter Cooling or heating jar by 120 mesh filter screens by colloidal mill;
(6) keep temperature in Cooling or heating jar, add remaining raw material stirring and dissolve.
7. the preparation method of the Halth-care composition with antiobesity action according to claim 6, it is characterised in that, described clean environment is 100,000 grades of clean environments.
8. the preparation method of the Halth-care composition with antiobesity action according to claim 6, it is characterised in that, described step (3) is specially:
Under 100,000 grades of clean environments, by the filtrate after above-mentioned purification, concentrated pressure is 0.05mpa, temperature is 60 DEG C, and the time is 12 hours, concentrate to relative density about 1.25, make concoction amount equal with the weight of the green tea originally dropped into, Semen Phaseoli Vulgaris, purple perilla, Roselle Calyx.
9. the preparation method of the Halth-care composition with antiobesity action according to claim 6, it is characterised in that, described preparation method also comprises after step (6):
(7) under 25mpa, the material after stirring being crossed clarifixator, temperature of charge remains on 70 DEG C;
(8) it is warming up to 80 DEG C and keeps constant temperature, filling;
(9) putting into sterilization cabinet sterilization after filling and sealing, 110 DEG C of sterilization 20min, obtain finished product.
10. the preparation method of the Halth-care composition with antiobesity action according to claim 9, it is characterised in that, described step (8) is specially:
It is warming up to 80 DEG C and keeps constant temperature, while it is filling to cross clarifixator limit, crosses 120 mesh filter screens before filling, stir filling.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610019687.2A CN105641215A (en) | 2016-01-13 | 2016-01-13 | Health product composition with weight-reducing effect and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610019687.2A CN105641215A (en) | 2016-01-13 | 2016-01-13 | Health product composition with weight-reducing effect and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105641215A true CN105641215A (en) | 2016-06-08 |
Family
ID=56487403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610019687.2A Pending CN105641215A (en) | 2016-01-13 | 2016-01-13 | Health product composition with weight-reducing effect and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105641215A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1863543A (en) * | 2003-10-06 | 2006-11-15 | 奥力榨油化株式会社 | Dietetic composition |
| CN101926891A (en) * | 2010-06-23 | 2010-12-29 | 北京康比特体育科技股份有限公司 | Composition for losing weight |
| CN102423073A (en) * | 2011-11-28 | 2012-04-25 | 李超建 | Diet for dietotherapy and health preservation |
| CN103055057A (en) * | 2012-08-31 | 2013-04-24 | 中国科学院生物物理研究所 | Plant weight-losing and fat-reducing composite compatible to L-carnitine |
| CN104041645A (en) * | 2014-06-04 | 2014-09-17 | 崔成哲 | Weight reducing and spirit raising coffee and making method thereof |
| CN104041644A (en) * | 2014-07-08 | 2014-09-17 | 胡伟斌 | Bowel relaxing tea and preparation method thereof |
| CN104621571A (en) * | 2015-03-12 | 2015-05-20 | 宁波高新区苗姑养生科技有限公司 | Strong body-building nutritional health-care food |
-
2016
- 2016-01-13 CN CN201610019687.2A patent/CN105641215A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1863543A (en) * | 2003-10-06 | 2006-11-15 | 奥力榨油化株式会社 | Dietetic composition |
| CN101926891A (en) * | 2010-06-23 | 2010-12-29 | 北京康比特体育科技股份有限公司 | Composition for losing weight |
| CN102423073A (en) * | 2011-11-28 | 2012-04-25 | 李超建 | Diet for dietotherapy and health preservation |
| CN103055057A (en) * | 2012-08-31 | 2013-04-24 | 中国科学院生物物理研究所 | Plant weight-losing and fat-reducing composite compatible to L-carnitine |
| CN104041645A (en) * | 2014-06-04 | 2014-09-17 | 崔成哲 | Weight reducing and spirit raising coffee and making method thereof |
| CN104041644A (en) * | 2014-07-08 | 2014-09-17 | 胡伟斌 | Bowel relaxing tea and preparation method thereof |
| CN104621571A (en) * | 2015-03-12 | 2015-05-20 | 宁波高新区苗姑养生科技有限公司 | Strong body-building nutritional health-care food |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178314B (en) | Bitter buckwheat health care beverage with auxiliary function for lowering blood pressure and production process thereof | |
| CN101822749B (en) | Medicinal preparation for curing hypertension and hyperlipaemia and preparation method thereof | |
| CN102551065B (en) | Blood sugar reducing food series | |
| CN107752024A (en) | A kind of nutritional meal replacing food for improving the metabolic disturbance diseases such as three height and obesity | |
| CN101642165B (en) | Method for preparing weight-reducing yoghurt beverage | |
| CN102125127B (en) | Functional highland barley red yeast rice tea and preparation method thereof | |
| CN108740620A (en) | A kind of prune clear beverage and preparation method thereof | |
| CN103478297B (en) | Healthcare sunflower seed oil with calcium supplementing function | |
| CN101356975B (en) | Health food capable of increasing human immunity and promoting intelligence and strengthening brain and preparation method thereof | |
| CN107801985A (en) | Containing Chinese yam, Semen Lablab Album, the membrane of a chicken's gizzard, the Chinese medicine composition of hawthorn and its application | |
| CN1706281A (en) | Health food with subsidiary function of lowering blood sugar and lowering blood fat and its production process | |
| CN111374313A (en) | Liquid meal replacement capable of controlling weight and preparation method thereof | |
| CN109876135B (en) | Eucommia ulmoides leaf and corn peptide composition capable of reducing blood pressure and blood fat and preparation method thereof | |
| CN107095300A (en) | A kind of biological nutrition compound composition of auxiliary treatment diabetes | |
| CN102613461A (en) | Rapidly beautifying and weight losing nourishment and preparation method thereof | |
| CN105641215A (en) | Health product composition with weight-reducing effect and preparation method thereof | |
| CN107372947B (en) | Tea bag type blood sugar reducing tea and preparation method thereof | |
| CN102784230A (en) | Pharmaceutical composition preparation for treating nutritional anemia | |
| CN105055670A (en) | Green tea and carnitine capsule with function of reducing weight | |
| KR101930145B1 (en) | Fasting supplement composition | |
| CN104256821A (en) | Maca compound oral liquid and preparation method thereof | |
| CN109757629A (en) | A kind of compound yacon liquid meal composition and its preparation and application | |
| CN114617949B (en) | Probiotic enzyme raw material treatment method with dampness eliminating and dysmenorrhea relieving functions | |
| CN108143972A (en) | A kind of slimming capsule with burn fat and preparation method thereof | |
| CN107242570A (en) | It is a kind of to improve the antifatigue health food of immunity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160608 |